CN Patent

CN105566229A — Btk抑制剂的苯磺酸盐及其用途和制备方法

Assigned to Avila Therapeutics Inc · Expires 2016-05-11 · 10y expired

What this patent protects

本申请涉及BTK抑制剂的苯磺酸盐及其用途和制备方法。本发明提供一种盐形式和其组合物，其适用作一种或一种以上蛋白质激酶的抑制剂并且展现所述抑制剂的所要特征。

USPTO Abstract

本申请涉及BTK抑制剂的苯磺酸盐及其用途和制备方法。本发明提供一种盐形式和其组合物，其适用作一种或一种以上蛋白质激酶的抑制剂并且展现所述抑制剂的所要特征。

Drugs covered by this patent

Patent Metadata

Patent number
CN105566229A
Jurisdiction
CN
Classification
—
Expires
2016-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Avila Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.